In addition, it has previously been reported that this axis promotes chemotherapy resistance in melanoma, as dacarbazine chemotherapy‐induced upregulation of CXCR2 by a nuclear factor kappa B (NF‐κB)‐dependent mechanism.89 The gene discussed is CXCR2; the disease is melanoma.